Grant Reed, DO
Family Medicine · Peru, ILNPI 1215354246
Payments from drug & device makers
Across 57 payments — averaging $13.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$156
- Lilly USA, LLC$101
- Amgen$93
- Sunovion Pharmaceuticals Inc.$82
- GSK$51
- Merck$40
- plus $273 from 12 others
What the payments were for
- Food & beverage$796100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 18 | $156 |
| Lilly USA, LLC | 4 | $101 |
| Amgen | 6 | $93 |
| Sunovion Pharmaceuticals Inc. | 2 | $82 |
| GSK | 4 | $51 |
| Merck | 3 | $40 |
| Johnson & Johnson | 1 | $40 |
| E.r. Squibb & Sons, L.L.C. | 3 | $39 |
| AstraZeneca | 3 | $39 |
| Boehringer Ingelheim | 2 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $22 |
| Philips North America LLC | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $20 |
| Novo Nordisk | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Radius Health, Inc. | 1 | $12 |
| AbbVie | 1 | $12 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
How this compares
$796 in reported general payments places this provider in the 70th percentile of 4,116 family medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 219 | $140,321 |
| OzempicSemaglutide | 76 | $78,601 |
| FarxigaDapagliflozin Propanediol | 63 | $46,819 |
| JardianceEmpagliflozin | 57 | $46,633 |
| XareltoRivaroxaban | 87 | $46,432 |
| TrulicityDulaglutide | 19 | $21,468 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 22 | $14,965 |
| JanuviaSitagliptin Phosphate | 14 | $14,083 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 18 | $13,811 |
| MyrbetriqMirabegron | 38 | $12,396 |
| Victoza 3-PakLiraglutide | 12 | $10,531 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 20 | $8,737 |
| Spiriva RespimatTiotropium Bromide | 16 | $8,396 |
| Incruse ElliptaUmeclidinium Bromide | 22 | $7,931 |
| Pregabalin | 84 | $6,647 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $156 | $140,321219 claims |
| Novo NordiskOzempic | $15 | $78,60176 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat, Stiolto Respimat | $29 | $61,04386 claims |
| AstraZenecaFarxiga, Symbicort | $39 | $53,23982 claims |
| Johnson & JohnsonXarelto | $40 | $46,43287 claims |
| GSKTrelegy Ellipta, Incruse Ellipta, Arnuity Ellipta | $51 | $27,47060 claims |
| Lilly USA, LLCTrulicity | $101 | $21,46819 claims |
| MerckJanuvia | $40 | $14,08314 claims |
| AbbVieSynthroid, Alphagan P | $12 | $5,46337 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Peru
- Daniel BruneCreve Coeur$15M
- Ali BajwaSpringfield$5.8M
- John ElsenEvergreen Park$5M
- Manohar JethaniBerwyn$4.9M
- Tiffany NguyenSkokie$3.9M
- Bradley TorphyChicago$3M
- Diana WidicusRochester$2.6M
- Nicholas WeberEureka$2.5M
- Stanley KochMorton$2.3M
- Mark ChristensenNew Lenox$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.